Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations

This e-book summarises the latest advances in the rheumatic diseases with a focus on the recent efforts of vascular and pulmonary manifestations and anticipate the new and future directions of these research topic. Rheumatic diseases represent a heterogeneous group of severe autoimmune disorders. Th...

Full description

Saved in:
Bibliographic Details
Other Authors: Ruaro, Barbara (Editor), Salton, Francesco (Editor), Confalonieri, Paola (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_80940
005 20220506
003 oapen
006 m o d
007 cr|mn|---annan
008 20220506s2022 xx |||||o ||| 0|eng d
020 |a books978-3-0365-3642-2 
020 |a 9783036536415 
020 |a 9783036536422 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-3642-2  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
072 7 |a MMG  |2 bicssc 
100 1 |a Ruaro, Barbara  |4 edt 
700 1 |a Salton, Francesco  |4 edt 
700 1 |a Confalonieri, Paola  |4 edt 
700 1 |a Ruaro, Barbara  |4 oth 
700 1 |a Salton, Francesco  |4 oth 
700 1 |a Confalonieri, Paola  |4 oth 
245 1 0 |a Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (178 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a This e-book summarises the latest advances in the rheumatic diseases with a focus on the recent efforts of vascular and pulmonary manifestations and anticipate the new and future directions of these research topic. Rheumatic diseases represent a heterogeneous group of severe autoimmune disorders. The present Special Issue aims to provide an overview of the complexity of vascular and pulmonary manifestations of rheumatologic diseases and helps in knowledge to manage them. The eleven published articles here collected underline the complexity of rheumatic diseases and the difficult to treated them. The manuscripts provide an overview of the pathophysiology and current treatment regimes of these disorders, highlighting tools which assist with diagnosis, risk stratification and therapy. Finally, we underline the importance of a multidisciplinary team working using the skills of clinicians, radiologists, and pathologists. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
650 7 |a Pharmacology  |2 bicssc 
653 |a systemic sclerosis 
653 |a scleroderma 
653 |a interstitial lung disease 
653 |a pulmonary function tests 
653 |a high-resolution computed tomography 
653 |a rheumatic 
653 |a pulmonary arterial hypertension 
653 |a targeted therapy 
653 |a systemic lupus erythematosus 
653 |a airway disease 
653 |a shrinking lung syndrome 
653 |a diffuse alveolar hemorrhage 
653 |a pleurisy 
653 |a infection 
653 |a cardiopulmonary exercise testing 
653 |a osteopontin 
653 |a connective tissue diseases 
653 |a pulmonary involvement 
653 |a microvascular involvement 
653 |a nailfold capillaroscopy 
653 |a rheumatoid arthritis 
653 |a interstitial lung diseases 
653 |a CX3CL1/fractalkine 
653 |a CX3CR1 
653 |a M1 macrophage 
653 |a M2 macrophage 
653 |a SKG mice 
653 |a heart failure 
653 |a 3D-echocardiography 
653 |a ventricular function 
653 |a outcome 
653 |a ventricular-arterial coupling 
653 |a antifibrotic agents 
653 |a COVID-19 
653 |a IPF 
653 |a progressive fibrosing ILD 
653 |a UIP 
653 |a pharmacological interactions 
653 |a fibromyalgia 
653 |a gastrointestinal symptoms 
653 |a probiotic 
653 |a VSL#3® 
653 |a efficacy 
653 |a tolerability 
653 |a polymyalgia rheumatica 
653 |a vagus nerve stimulation 
653 |a inflammatory response 
653 |a PMR 
653 |a t-vns 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/5278  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/80940  |7 0  |z DOAB: description of the publication